Herbs Era Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 49 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
About Herbs Era Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Supriyo Datta and Debadrita Datta serve as directors at the Company.
- CIN/LLPIN
U24231WB1975PTC030271
- Company No.
030271
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Oct 1975
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Herbs Era Pharmaceuticals Pvt Ltd offer?
Herbs Era Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Pharmaceutical Medicine, Pharmaceutical Syrup, Liquid Orals, Ayurvedic Digestive Medicine, Digestive Herbal Capsule & Tablet, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Brain Tonic, Ayurvedic Health Tonic, Herbal Uterine Tonic, Ayurvedic Digestive Syrups.
Who are the key members and board of directors at Herbs Era Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Supriyo Datta  | Additional Director | 16-Aug-2008 | Current |
| Debadrita Datta | Additional Director | 06-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Herbs Era Pharmaceuticals.
Herbs Era Pharmaceuticals Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Herbs Era Pharmaceuticals?
In 2017, Herbs Era Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Teamace Educational Services Private LimitedActive 9 years 6 months
Supriyo Datta is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Herbs Era Pharmaceuticals?
Herbs Era Pharmaceuticals has a workforce of 7 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Herbs Era Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Herbs Era Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
